Analgesic effects of botulinum neurotoxin type A in a model of allyl isothiocyanate- and capsaicin-induced pain in mice. (February 2015)

• Record Type: Journal Article
• Authors: Luvisetto, Siro; Vacca, Valentina; Cianchetti, Carlo
• Is Part Of: Toxicon. Volume 94(2015)
• Page Start: 23
• Page End: 28
• Publication Date: 2015-02
• Subjects: Capsaicin -- Allyl isothiocyanate -- Botulinum -- TRPV1 -- TRPA1 -- Behavior; Toxins -- Periodicals; Venom -- Periodicals; 615.9
• DOI: 10.1016/j.toxicon.2014.12.007
• Languages: English
• ISSNs: 0041-0101

Abstract

Abstract: We evaluate analgesic effects of BoNT/A in relation to the two main transient receptor potentials (TRP), the vanilloid 1 (TRPV1) and the ankyrin 1 (TRPA1), having a role in migraine pain. BoNT/A (15 pg/mouse) was injected in the inner side of the medial part of hindlimb thigh of mice, where the superficial branch of femoral artery is located. We chosen this vascular structure because it is similar to other vascular structures, such as the temporal superficial artery, whose perivascular nociceptive fibres probably contributes to migraine pain. After an interval, ranging from 7 to 30 days, capsaicin (agonist of TRPV1) or allyl isothiocyanate (AITC; agonist of TRPA1) were injected in the same region previously treated with BoNT/A and nocifensive response to chemicals-induced pain was recorded. In absence of BoNT/A, capsaicin and AITC induced extensive nocifensive response, with a markedly different temporal profile: capsaicin induced maximal pain during the first 5 min, while AITC induced maximal pain at 15–30 min after injection. Pretreatment with BoNT/A markedly reduced both the capsaicin- and AITC-induced pain for at least 21 days. These data suggest a long lasting analgesic effect of BoNT/A exerted via prevention of responsiveness of TRPV1 and TRPA1 toward their respective agonists. Highlights: We suggest the injection of irritants close to superficial trunk of femoral artery as new inflammatory pain model. Injection of capsaicin or allyl isothiocyanate near the femoral artery in mice evokes a nocifensive response. Botulinum toxin A acts as analgesic by inhibiting transient receptor potential vanilloid 1 and ankyrin 1 channels.